Insulet Corp. (PODD) stock forecast and price target
Price $152.48 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($152.48)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $6.77 | +36.3% | $3.3B |
| Next fiscal year ends December 31, 2027 | $7.91 | +16.8% | $3.7B |
| Next quarter ends December 31, 2026 | $1.75 | +13.1% | $900M |
| Quarter after ends March 31, 2027 | $1.66 | +16.7% | $851M |
Consensus of the analysts covering Insulet, updated daily. In the last 30 days 16 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 17.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Insulet’s intrinsic value about 47% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Insulet stock price target?
The average 12-month target from 23 analysts is $178.57, 17.1% above the current price of $152.48 Targets range from $160.00 to $200.00.
Is Insulet a buy according to analysts?
The consensus rating is “Buy” (4 strong buy, 11 buy, 11 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Insulet expected to earn?
Analysts expect EPS of $6.77 for the fiscal year ending December 31, 2026 and $7.91 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.